EC Number | Application | Comment | Organism |
---|---|---|---|
2.7.7.81 | medicine | Helicobacter pylori, heavily modifies its flagellin with pseudaminic acid. Because this sugar is unique to bacteria, its biosynthetic pathway offers potential as a novel therapeutic target | Helicobacter pylori |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.5.1.97 | expression in Escherichia coli | Helicobacter pylori |
2.7.7.81 | expression in Escherichia coli | Helicobacter pylori |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.7.7.81 | Mg2+ | required for optimal activity | Helicobacter pylori |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.5.1.97 | phosphoenolpyruvate + 2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose + H2O | Helicobacter pylori | pseudaminic acid biosynthesis | phosphate + 5,7-bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid | - |
? | |
2.7.7.81 | CTP + 5,7-bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid | Helicobacter pylori | CMP-pseudaminic acid biosynthesis. Helicobacter pylori, heavily modifies its flagellin with pseudaminic acid, a modification that influences pathogenesis through bacterial adhesion, invasion, and immune evasion | diphosphate + CMP-5,7-bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid | - |
? | |
4.2.1.115 | UDP-N-acetylglucosamine | Helicobacter pylori | production of a precursor of pseudaminic acid, i.e. 5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-nonulosonic acid, required for flagellin glycosylation in Helicobacter pylori, analysis of all reaction steps in the pathway and related enzymes, overview | UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose + H2O | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.202 | Helicobacter pylori | - |
- |
- |
2.5.1.97 | Helicobacter pylori | - |
- |
- |
2.7.7.81 | Helicobacter pylori | - |
- |
- |
4.2.1.115 | Helicobacter pylori | - |
gene pseB | - |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.5.1.97 | - |
Helicobacter pylori |
2.7.7.81 | - |
Helicobacter pylori |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.202 | acetyl-CoA + UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine | N-4-acetylation | Helicobacter pylori | CoA + UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose | - |
? | |
2.5.1.97 | phosphoenolpyruvate + 2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose + H2O | pseudaminic acid biosynthesis | Helicobacter pylori | phosphate + 5,7-bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid | - |
? | |
2.5.1.97 | phosphoenolpyruvate + 2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose + H2O | combining the five enzymes of pseudaminic acid biosynthesis (PseB, PseC, PseH, PseG, PseI) in a one-pot reaction results in 100% conversion of UDP-N-acetylglucosamine to pseudaminic acid after 20 h | Helicobacter pylori | phosphate + 5,7-bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid | - |
? | |
2.7.7.81 | CTP + 5,7-bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid | CMP-pseudaminic acid biosynthesis. Helicobacter pylori, heavily modifies its flagellin with pseudaminic acid, a modification that influences pathogenesis through bacterial adhesion, invasion, and immune evasion | Helicobacter pylori | diphosphate + CMP-5,7-bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid | - |
? | |
2.7.7.81 | CTP + 5,7-bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid | when all six CMP-pseudaminic acid biosynthetic enzymes (PseB, PseC, PseH, PseG, PseI, PseF) are combined in a reaction with UDP-N-acetylglucosamine, synthesis of VII is successful CMP-pseudaminic acid. Combining the first five enzymes (PseB, PseC, PseH, PseG, PseI) in a one-pot reaction results in 100% conversion of UDP-N-acetylglucosamine to pseudaminic acid after 20 h | Helicobacter pylori | diphosphate + CMP-5,7-bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid | - |
? | |
4.2.1.115 | UDP-N-acetylglucosamine | - |
Helicobacter pylori | UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose + H2O | - |
? | |
4.2.1.115 | UDP-N-acetylglucosamine | production of a precursor of pseudaminic acid, i.e. 5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-nonulosonic acid, required for flagellin glycosylation in Helicobacter pylori, analysis of all reaction steps in the pathway and related enzymes, overview | Helicobacter pylori | UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose + H2O | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.202 | CMP-pseudaminic acid N-acetyltransferase | - |
Helicobacter pylori |
2.3.1.202 | PsEH | - |
Helicobacter pylori |
2.5.1.97 | PseI | - |
Helicobacter pylori |
2.7.7.81 | PseF | - |
Helicobacter pylori |
4.2.1.115 | NAD(P)+-dependent dehydratase/epimerase | - |
Helicobacter pylori |
4.2.1.115 | PseB | - |
Helicobacter pylori |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
4.2.1.115 | 25 | - |
assay at | Helicobacter pylori |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.7.7.81 | 9 | - |
alkaline pH is required for optimal activity | Helicobacter pylori |
4.2.1.115 | 7.3 | - |
assay at | Helicobacter pylori |